Eurobio Scientific S.A. (ALERS.PA) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

+118.7%

€57.75

vs €26.40 price

Levered DCF

€78.33

After debt service

Piotroski score

6 / 9

Average

Altman Z-score

1.99

Grey zone

Rating

A-

Overall 4 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
P/E	51.81×	64.74×	38.23×	9.25×	4.82×	2.58×	16.17×	-10.95×
P/B	1.36×	1.45×	1.05×	1.21×	1.83×	1.77×	1.4×	1.01×
P/S	1.48×	1.67×	1.4×	1.36×	1.58×	1.01×	0.86×	0.59×
EV / EBITDA	7.57×	9.33×	9.56×	6.82×	2.7×	1.75×	8.93×	5.61×
Gross margin	40.5%	46.4%	44.0%	42.6%	52.8%	55.9%	30.8%	34.4%
Operating margin	9.1%	8.6%	7.8%	20.2%	39.0%	43.0%	1.0%	-2.3%
Net margin	2.9%	2.6%	3.7%	16.3%	32.8%	38.9%	5.3%	-5.4%
Current ratio	1.98×	2.03×	2.72×	2.59×	4.79×	2.82×	1.27×	1.34×
Debt / equity	0.09×	0.19×	0.57×	0.66×	0.1×	0.28×	0.53×	0.8×
Interest coverage	7.73×	2.39×	2.29×	23.97×	158.21×	131.2×	0.76×	-1.14×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Return on equity	2.6%	2.2%	2.8%	14.5%	37.9%	68.6%	8.6%	-9.3%
Return on invested capital	4.5%	3.9%	2.5%	9.0%	34.3%	52.8%	1.1%	-2.2%
Return on assets	1.9%	1.6%	1.5%	7.5%	28.9%	42.6%	3.9%	-4.0%
Free cash flow yield	2.5%	5.2%	12.4%	18.7%	21.8%	27.4%	6.6%	-7.2%
Earnings yield	1.9%	1.5%	2.6%	12.0%	20.7%	38.7%	6.2%	-9.2%
Enterprise value	€245.3M	€271.1M	€234.7M	€274.3M	€214.8M	€154.6M	€63.4M	€43.9M
Net debt / EBITDA	-0.13×	0.42×	2.09×	1.64×	-0.97×	-0.4×	1.72×	1.77×
Cash conversion cycle (days)	110	129	130	109	131	125	97	37